Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance.
- NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_assertion description "[Moreover, treatment of WT mice with soluble ObR fusion protein (ObR:Fc) increased the percentage of T(Regs) and ameliorated the clinical course and progression of disease in proteolipid protein peptide (PLP(139-151))-induced relapsing-experimental autoimmune encephalomyelitis (R-EAE), an animal model of RRMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance.
- NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_assertion evidence source_evidence_literature NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance.
- NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_assertion SIO_000772 15788534 NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance.
- NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_assertion wasDerivedFrom befree-2016 NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance.
- NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_assertion wasGeneratedBy ECO_0000203 NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance.
- befree-2016 importedOn "2016-02-19" NP486938.RAAK2Lj2qmmweQBGcq_a5c0OGlibfCpzu-j5136r2gE2o130_provenance.